Navonil DS

If you or a loved one has prostate cancer, germline genetic and somatic testing can open doors—to better treatment options, clinical trials, and a clearer picture of your family's cancer risk. Medical oncologist Dr. @EHeath4100 walks you through: bit.ly/47wv4Qt #MedEd

Basketball Hall of Fame checks in to Prostate Cancer Foundation effort to save lives mmm-online.com/news/basketbal… @PCFnews

We infer earthquakes from distant vibrations and stars from photons emitted light-years away. Can we reconstruct a patient’s tumor biology from the signals it sheds into blood? Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma. Preprint: biorxiv.org/content/10.648… @biorxivpreprint @DanaFarber @DrChoueiri @SylvanBacaLab #FreedmanLab

Cholesterol synthesis fuels androgen growth in SPOP/CHD1-altered #Prostate tumors. @Dr_Di_Zhao @MDAndersonNews joins @AndreaMiyahira @PCFnews a @NatureCancer study examining CHD1 loss and SPOP mutations in #ProstateCancer. The team demonstrated that combining FDA-approved atorvastatin with abiraterone showed synergistic anti-tumor effects in preclinical models. #WatchNow to learn more > bit.ly/49j6pQW

The 32nd Annual #PCFRetreat25 brought together the brightest minds in #ProstateCancer research to discuss groundbreaking science, collaboration and innovation. Here's to continued breakthroughs in research ahead. #Research #Innovation #ThinkTank